Simulect
List of products in the National Drug Code with proprietary name simulect. Basiliximab is used to prevent organ rejection in people who have received a kidney transplant. It is usually taken along with other medications (e.g., cyclosporine, corticosteroids) to allow your new organ to function normally. Basiliximab is an immunosuppressant drug known as a monoclonal antibody. It works by slowing down your body's defense system (immune system) to prevent your body from rejecting the new kidney after surgery (acute rejection).
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
0078-0331 | Simulect | Basiliximab | Injection, Powder, For Solution | Intravenous | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0393 | Simulect | Basiliximab | Injection, Powder, For Solution | Intravenous | Novartis Pharmaceuticals Corporation | Human Prescription Drug |